|
Market Closed -
NYSE
01:30:02 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 249.57 USD | -2.37% |
|
-1.77% | +21.45% |
| 21/10 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 21/10 | Cencora to acquire American Oncology Network in $2.4 billion deal | RE |
| Market Cap | 5.78TCr 5.16TCr 4.77TCr 4.32TCr 8.08TCr 5,48600Cr 8.22TCr 57TCr 23TCr 2,87400Cr 22TCr 21TCr 9,06200Cr | P/E 2027 * |
24.4x | P/E 2028 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 5.97TCr 5.33TCr 4.92TCr 4.46TCr 8.35TCr 5,66400Cr 8.48TCr 59TCr 23TCr 2,96800Cr 22TCr 22TCr 9,35600Cr | EV / Sales 2027 * |
0.22x | EV / Sales 2028 * | 0.21x |
| Free-Float |
85.66% | Yield 2027 * |
0.84% | Yield 2028 * | 0.86% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CAH | Delayed | |
CBOE
| CAH | Real-time | |
|
London S.E.
| 0HTG | Delayed | |
|
Tradegate
| CLH | Real-time | |
|
Deutsche Boerse AG
| CLH | Delayed | |
|
Mexican S.E.
| CAH * | End-of-day quote | |
|
Boerse Muenchen
| CLH | Real-time | |
|
Xetra
| CLH | Delayed | |
|
Börse Stuttgart
| CLH | Delayed | |
|
Berne S.E.
| CLH | End-of-day quote | |
|
Borsa Italiana
| 1CAH | End-of-day quote | |
|
Wiener Boerse
| CAHE | End-of-day quote |
Last Transcript: Cardinal Health, Inc.
| 1 day | +0.18% | ||
| 1 week | -1.77% | ||
| Current month | +12.17% | ||
| 1 month | +12.79% | ||
| 3 months | +10.44% | ||
| 6 months | +21.91% | ||
| Current year | +21.45% |
| 1 week | 249.24 |  | 259.21 |
| 1 month | 216.7 | | 259.21 |
| Current year | 180.45 | | 259.21 |
| 1 year | 161.36 | | 259.21 |
| 3 years | 90.19 | | 259.21 |
| 5 years | 45.85 | | 259.21 |
| 10 years | 39.05 | | 259.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 53 | 01/09/2022 |
Aaron Alt
DFI | Director of Finance/CFO | 55 | 10/02/2023 |
Ben Brinker
COO | Chief Operating Officer | - | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 20/03/2026 | |
Nancy Killefer
BRD | Director/Board Member | 71 | 14/09/2015 |
Akhil Johri
BRD | Director/Board Member | 64 | 07/02/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/08/26 | Sell | Chief Executive Officer | -44,529 | 0.0190% | ||
| 19/08/26 | Sell | Controller/Auditor | -2,302 | 0.0010% | ||
| 18/08/26 | Sell | Executive/Senior Manager | -7,354 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.37% | -1.77% | +56.80% | +171.30% | 5.78TCr | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,13500Cr | |
| -1.42% | +3.23% | +37.07% | +74.26% | 64TCr | |
| +0.16% | +0.08% | +25.14% | +97.36% | 50TCr | |
| -0.31% | +3.09% | +43.92% | +64.55% | 38TCr | |
| -1.34% | -0.47% | +66.63% | +40.56% | 36TCr | |
| -0.68% | +2.65% | +22.46% | +51.48% | 29TCr | |
| -1.20% | +3.04% | +2.62% | +26.97% | 27TCr | |
| -1.79% | +1.57% | +49.97% | +60.87% | 24TCr | |
| -0.73% | -0.10% | +29.24% | +101.19% | 19TCr | |
| Average | -0.58% | +1.77% | +38.90% | +80.94% | 40.62TCr | |
| Weighted average by Cap. | -0.25% | +2.60% | +41.22% | +83.40% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27TCr 24TCr 22TCr 20TCr 37TCr 25,22900Cr 38TCr 2,63800Cr 1,04500Cr 13,21800Cr 1LCr 98TCr 41,67400Cr | 28TCr 25TCr 23TCr 21TCr 39TCr 26,75600Cr 40TCr 2,79800Cr 1,10800Cr 14,01900Cr 1,05800Cr 1,03500Cr 44,19600Cr |
| Net income | 232.35Cr 207.49Cr 191.68Cr 173.7Cr 324.98Cr 22TCr 330.36Cr 2.31TCr 913.21Cr 12TCr 871.99Cr 853.44Cr 36TCr | 261.05Cr 233.12Cr 215.36Cr 195.16Cr 365.12Cr 25TCr 371.16Cr 2.59TCr 1.03TCr 13TCr 979.69Cr 958.86Cr 41TCr |
| Net Debt | 187.47Cr 167.41Cr 154.66Cr 140.15Cr 262.21Cr 18TCr 266.54Cr 1.86TCr 736.81Cr 9.32TCr 703.56Cr 688.6Cr 29TCr | 37Cr 33Cr 31Cr 28Cr 52Cr 3.51TCr 53Cr 367.29Cr 145.41Cr 1.84TCr 138.85Cr 135.9Cr 5.8TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $249.57 | -2.37% | 16,65,848 |
| 22/26/22 | $255.64 | -0.71% | 14,97,794 |
| 21/26/21 | $257.46 | -0.03% | 15,86,656 |
| 20/26/20 | $257.55 | +1.94% | 19,09,495 |
| 19/26/19 | $252.65 | -0.55% | 37,81,726 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions
